IVD Medical Holding Limited — Investor Relations & Filings

IVD Medical Holding Limited is an AI Medical Capital Operation Platform focused on integrating global AI healthcare segment leaders through strategic mergers and acquisitions (M&A). The company's operational framework is built on three synergistic curves. The K1 curve utilizes its established In Vitro Diagnostic (IVD) distribution network, which includes its position as the exclusive Tier 1 distributor for Sysmex's haemostasis products in China, providing critical market entry and clinical integration for acquired assets. The K2 curve fosters an ecosystem for aggregating and synergizing IVD and AI medical intellectual property. The K3 curve employs capital operation tools, such as IP securitization, to define value and accelerate the capital appreciation of advanced medical assets. This strategy aims to drive the commercialization of cutting-edge AI medical solutions and reshape the global healthcare value chain.